Are you Dr. Rasila?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2702 Low Ct
Fairfield, CA 94534Phone+1 707-427-4900
Summary
- Dr. Kanwaldeep (Kaur) Rasila, MD is an oncologist in Fairfield, California. She is currently licensed to practice medicine in California, New Mexico, and Illinois. She is affiliated with Sutter Solano Medical Center, Sutter Davis Hospital, and Sutter Medical Center, Sacramento.
Education & Training
- University of New Mexico School of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2006
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 2000 - 2003
- Dayanand Medical College Class of 1998
Certifications & Licensure
- CA State Medical License 2011 - 2026
- NM State Medical License 2003 - 2012
- IL State Medical License 2000 - 2003
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 4 citationsPhase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocolsAlonso V. Pacheco, Kanwaldeep Kaur Rasila, Sang Joon Lee, Ian Rabinowitz, Laurence Elias
Urologic Oncology. 2008-11-01 - 52 citationsThe SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylationElizabeth A. Williamson, Kanwaldeep Kaur Rasila, Lori Kwan Corwin, Justin Wray, Brian D. Beck
Nucleic Acids Research. 2008-10-01 - 106 citationsThe chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy.Trevor Starnes, Kanwaldeep Kaur Rasila, Michael J. Robertson, Zacharie Brahmi, Richard Dahl
Experimental Hematology. 2006-08-01
Professional Memberships
- Member